CAJ | 학술논문

目的评价检测恶性肿瘤患者血清CA125、CA242、CA153水平的临床价值.方法用酶联免疫吸附法测定97例四种恶性肿瘤患者血清CA125、CA242、CA153的含量.结果:肺癌患者血清CA125、CA242、CA153水平明显高于正常对照组(P＜0.01或P＜0.05),肺腺癌患者血清CA125水平明显高于肺鳞癌(P＜0.05),肺癌Ⅳ期患者血清三种肿瘤标志物含量明显高于Ⅲ期(P＜0.01或P＜0.05),宫颈癌和非何杰金氏淋巴瘤(NHL)患者血清CA125水平明显高于对照组(P＜0.01或P＜0.05),宫颈癌Ⅳ期血清CA125水平明显高于Ⅱ、Ⅲ期(P＜0.05),肺癌患者血清CA125水平明显高于鼻咽癌患者(P＜0.05).血清CA125敏感性高低依次是肺癌＞NHL＞宫颈癌＞鼻咽癌(P＜0.05).结论血清CA125 CA242、CA153水平检测对恶性肿瘤的诊断及分期有一定参考价值.
목적평개검측악성종류환자혈청CA125、CA242、CA153수평적림상개치.방법용매련면역흡부법측정97례사충악성종류환자혈청CA125、CA242、CA153적함량.결과:폐암환자혈청CA125、CA242、CA153수평명현고우정상대조조(P＜0.01혹P＜0.05),폐선암환자혈청CA125수평명현고우폐린암(P＜0.05),폐암Ⅳ기환자혈청삼충종류표지물함량명현고우Ⅲ기(P＜0.01혹P＜0.05),궁경암화비하걸금씨림파류(NHL)환자혈청CA125수평명현고우대조조(P＜0.01혹P＜0.05),궁경암Ⅳ기혈청CA125수평명현고우Ⅱ、Ⅲ기(P＜0.05),폐암환자혈청CA125수평명현고우비인암환자(P＜0.05).혈청CA125민감성고저의차시폐암＞NHL＞궁경암＞비인암(P＜0.05).결론혈청CA125 CA242、CA153수평검측대악성종류적진단급분기유일정삼고개치.